Medication Review, Inc. — Form D
Medication Review, Inc. of SPOKANE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-21. The offering totals $400K, of which $195K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-09-21
- Form: D
- Accession: 0001497310-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06, 46
- Total offering: $400K
- Amount sold: $195K
- Remaining: $205K
- Minimum investment: $10K
- Investors: 6
- Date of first sale: 2010-09-15
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-147979
Issuer
- Name: Medication Review, Inc.
- CIK: 0001497310
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2005
- Address: 104 S. FREYA, SPOKANE, WA, 99202
- Phone: 509-343-5200
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Adam R Gelhausen | Executive Officer | Spokane, WA |
| Dennis R Hake | Executive Officer | Spokane, WA |
| Chris R Terriff, RPh | Executive Officer | Spokane, WA |
| K. Douglas Crafton | Director | Spokane, WA |
| K. Douglas Crafton | Executive Officer | Spokane, WA |
| Tom R Jensen, MPA | Director | Spokane, WA |
| Christopher R Terriff, RPh | Executive Officer | Spokane, WA |
| James F Karel, MS | Director | Spokane, WA |
| Mary R Giannini | Director | Spokane, WA |
| Michael R Anderegg | Executive Officer | Spokane, WA |
| Kyle R Downey, PharmD | Executive Officer | Spokane, WA |
| Linda F Garrelts-MacLean, BPharm, RPh | Director | Spokane, WA |
Other filings by this issuer (1)
More